Melanocortin Receptor Type 3 as a Potential Target for Anti-Inflammatory Therapy

E-ISSN： 1875-5933|3|3|311-315

ISSN： 1568-010X

Source： Current Drug Targets. Inflammation & Allergy, Vol.3, Iss.3, 2004-09, pp. : 311-315

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Melanocortin peptides and their receptors: new targets for anti-inflammatory therapy

By Getting S.J.

Trends in Pharmacological Sciences, Vol. 23, Iss. 10, 2002-10 ,pp. : 447-449

Elsevier

Access to resources Recommend Favorite

The anti-inflammatory effect of A₃ adenosine receptor agonists: a novel targeted therapy for rheumatoid arthritis

By Bar-Yehuda Sara Silverman Michael H Kerns William D Ochaion Avivit Cohen Shira Fishman Pnina

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 10, 2007-10 ,pp. : 1601-1613

Informa Healthcare

Access to resources Recommend Favorite

MK2: a novel molecular target for anti-inflammatory therapy

By Duraisamy Senthil Bajpai Malini Bughani Usha Dastidar Sunanda G Ray Abhijit Chopra Puneet

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 8, 2008-08 ,pp. : 921-936

Informa Healthcare

Access to resources Recommend Favorite

Novel Anti-inflammatory Interleukin-35 as an Emerging Target for Antiatherosclerotic Therapy

Current Pharmaceutical Design, Vol. 21, Iss. 9, 2015-03 ,pp. : 1147-1151

Bentham Science Publishers

Access to resources Recommend Favorite

The Emerging Role of the Histamine H4 Receptor in Anti-inflammatory Therapy

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 13, 2006-07 ,pp. : 1365-1373

Bentham Science Publishers

Access to resources Recommend Favorite